GNAS Gene Pseudohypoparathyroidism Type 1B Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

DHA Certified

تحليل جين GNAS لتشخيص قصور الدريقات الكاذب من النوع 1B باستخدام التسلسل الجيني من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

ملخص تنفيذي: فحص جيني معتمد لتحديد الطفرات المسببة لقصور الدريقات الكاذب نوع 1B، وفق معايير الجودة العالمية وتعليمات هيئة الصحة بدبي.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

ISO 9001:2015 Cert: INT/EGQ/2509DA/3139

Test Overview

The GNAS Gene Pseudohypoparathyroidism type 1B NGS test detects pathogenic variants in the GNAS gene associated with pseudohypoparathyroidism type 1B (PHP1B), a rare endocrine disorder. This advanced Next Generation Sequencing analysis provides comprehensive genetic profiling with 99.9% diagnostic accuracy, enabling precise diagnosis and personalized management.

يكشف هذا الاختبار المتطور عن الطفرات الجينية في جين GNAS المسببة لمرض قصور الدريقات الكاذب من النوع 1B، مما يسمح بالتشخيص الدقيق والإرشاد الوراثي.

Feature	Our Test (GNAS NGS)	Closest Alternative (Sanger Sequencing)
Precision	99.9% sensitivity, full gene coverage	Limited to known hotspots
Method	Next Generation Sequencing (NGS)	Sanger sequencing, single exon analysis
Turnaround Time	3-4 Weeks	2-3 Weeks
Cost	2800 AED	Varies (2500-3500 AED)

Physician Insight & Safety Protocol

“As a clinician with over 25 years of experience, I emphasize that a positive GNAS mutation finding must be interpreted within the patient’s full clinical picture, including calcium and PTH levels. Genetic results are only one part of the diagnostic puzzle; correlation with biochemical and radiological data is essential for accurate diagnosis and treatment planning. Please do not alter any medication without prior consultation with your healthcare provider.” — Dr. PRABHAKAR REDDY (DHA License: 61713011)

Medication Warning:

Do not discontinue prescribed medication without consulting your doctor. This test does not replace clinical evaluation or medication management.

Exclusion Criteria & Safety Red Flags

Acute severe illness or hospitalized patients not eligible for home collection.
Known anaphylactic reaction to phlebotomy equipment materials.
ER Red Flags: If you experience severe hypocalcemic symptoms (tetany, seizures, laryngospasm, cardiac arrhythmias) while awaiting results, seek emergency medical attention immediately.

Patient FAQ & Clinical Guidance

1. What is the purpose of the GNAS Pseudohypoparathyroidism type 1B NGS test?

يكشف تحليل الجين GNAS عن الطفرات الجينية المسببة لقصور الدريقات الكاذب من النوع 1B، مما يؤكد التشخيص السريري بدقة عالية ويساعد في توجيه العلاج والاستشارة الوراثية.

This advanced DNA test sequences the entire GNAS gene to identify pathogenic mutations linked to PHP1B, enabling a definitive molecular diagnosis and informing family genetic counseling.

2. How is the sample collected and what is the turnaround time?

يتم جمع العينة بسهولة في المنزل عن طريق سحب الدم أو استخدام بطاقة FTA لبقعة دم واحدة، مع مدة إنجاز تتراوح بين 3 إلى 4 أسابيع.

Our VIP mobile phlebotomy team collects a small blood sample in the comfort of your home (whole blood, extracted DNA, or a single drop on an FTA card). Results are delivered in 3-4 weeks with secure digital reporting.

3. Is genetic counseling mandatory before testing?

يوصى بشدة بجلسة استشارة وراثية مسبقة لرسم شجرة العائلة وتقييم المخاطر، وهي شرط أساسي ضمن الإجراءات المعتمدة من هيئة الصحة بدبي.

Yes, a pre- genetic counseling session is required to construct a detailed pedigree chart of affected family members and discuss implications. This service is included as part of our comprehensive care protocol under DHA guidelines.

دعم ثنائي اللغة متاح